SEC Filings | Celldex Therapeutics

Form	Description	Filing date	View
4	Statement of changes in beneficial ownership of securities	Jun 17, 2022	View HTML 0001415889-22-006696.pdf 0001415889-22-006696.rtf 0001415889-22-006696.xls
4	Statement of changes in beneficial ownership of securities	Jun 17, 2022	View HTML 0001415889-22-006700.pdf 0001415889-22-006700.rtf 0001415889-22-006700.xls
4	Statement of changes in beneficial ownership of securities	Jun 17, 2022	View HTML 0001415889-22-006705.pdf 0001415889-22-006705.rtf 0001415889-22-006705.xls
4	Statement of changes in beneficial ownership of securities	Jun 17, 2022	View HTML 0001415889-22-006708.pdf 0001415889-22-006708.rtf 0001415889-22-006708.xls
4	Statement of changes in beneficial ownership of securities	Jun 17, 2022	View HTML 0001415889-22-006709.pdf 0001415889-22-006709.rtf 0001415889-22-006709.xls
4	Statement of changes in beneficial ownership of securities	Jun 17, 2022	View HTML 0001415889-22-006712.pdf 0001415889-22-006712.rtf 0001415889-22-006712.xls
4	Statement of changes in beneficial ownership of securities	Jun 17, 2022	View HTML 0001415889-22-006716.pdf 0001415889-22-006716.rtf 0001415889-22-006716.xls
4	Statement of changes in beneficial ownership of securities	Jun 17, 2022	View HTML 0001415889-22-006722.pdf 0001415889-22-006722.rtf 0001415889-22-006722.xls
4	Statement of changes in beneficial ownership of securities	Jun 17, 2022	View HTML 0001415889-22-006718.pdf 0001415889-22-006718.rtf 0001415889-22-006718.xls
4	Statement of changes in beneficial ownership of securities	Jun 17, 2022	View HTML 0001415889-22-006728.pdf 0001415889-22-006728.rtf 0001415889-22-006728.xls

Data provided by Kaleidoscope.